JP2015512247A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512247A5
JP2015512247A5 JP2015500780A JP2015500780A JP2015512247A5 JP 2015512247 A5 JP2015512247 A5 JP 2015512247A5 JP 2015500780 A JP2015500780 A JP 2015500780A JP 2015500780 A JP2015500780 A JP 2015500780A JP 2015512247 A5 JP2015512247 A5 JP 2015512247A5
Authority
JP
Japan
Prior art keywords
scfv
compound
snap
receptors
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015500780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/055022 external-priority patent/WO2013139391A1/en
Publication of JP2015512247A publication Critical patent/JP2015512247A/ja
Publication of JP2015512247A5 publication Critical patent/JP2015512247A5/ja
Pending legal-status Critical Current

Links

JP2015500780A 2012-03-21 2012-03-21 光線力学的療法に使用するための新規光免疫複合体 Pending JP2015512247A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/055022 WO2013139391A1 (en) 2012-03-21 2012-03-21 Novel photoimmunoconjugates for use in photodynamic therapy

Publications (2)

Publication Number Publication Date
JP2015512247A JP2015512247A (ja) 2015-04-27
JP2015512247A5 true JP2015512247A5 (enExample) 2015-06-11

Family

ID=45855805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015500780A Pending JP2015512247A (ja) 2012-03-21 2012-03-21 光線力学的療法に使用するための新規光免疫複合体

Country Status (8)

Country Link
US (1) US9872904B2 (enExample)
EP (1) EP2827906A1 (enExample)
JP (1) JP2015512247A (enExample)
KR (1) KR20150003719A (enExample)
CN (1) CN104203286B (enExample)
CA (1) CA2866933C (enExample)
IN (1) IN2014DN06866A (enExample)
WO (1) WO2013139391A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524239B2 (en) 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
CA2954463C (en) 2014-08-08 2023-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photo-controlled removal of targets in vitro and in vivo
WO2016202365A1 (en) * 2015-06-16 2016-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Specific photoimmuno-theranostics for detection and elimination of skin cancer cells
EP3331909B1 (en) * 2015-08-07 2026-04-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Near infrared photoimmunotherapy (nir-pit) of suppressor cells to treat cancer
EP3337514B8 (en) 2015-08-18 2022-04-06 Rakuten Medical, Inc. Composition comprising a conjugate comprising a phthalocyanine dye linked to a targeting molecule for photoimmunotherapy
AU2016308286B2 (en) 2015-08-18 2022-04-07 Rakuten Medical, Inc. Phthalocyanine dye conjugates and their storage
KR102061322B1 (ko) 2017-03-21 2019-12-31 한국과학기술원 항-cd25 단일클론 항체-광감각제 복합체를 포함하는 암 예방 또는 치료용 약학 조성물
JP7398115B2 (ja) 2017-12-22 2023-12-14 ノース カロライナ ステート ユニバーシティ ポリマーフルオロフォア、それを含む組成物、ならびにその調製および使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191702T3 (es) 1994-03-17 2003-09-16 Merck Patent Gmbh Fv monocatenarios anti-egfr y anticuerpos anti-egfr.
ZA952174B (en) * 1994-03-17 1995-12-27 Merck Patent Gmbh Anti-EGFR single-chain fvs and anti-EGFR antibodies
US6936469B2 (en) * 2001-03-22 2005-08-30 Chromos Molecular Systems Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
AU2004205898B2 (en) 2003-01-17 2009-11-19 The Research Foundation Of State University Of New York Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
EP1882688A1 (en) 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
WO2009013359A2 (en) 2007-07-25 2009-01-29 Fraunhofer Gesellschaft Zur Förderung Der Angewandten Forschung E. V. Self coupling recombinant antibody fusion proteins

Similar Documents

Publication Publication Date Title
JP2022065174A5 (enExample)
JP2020114828A5 (enExample)
US10960083B2 (en) Binding protein drug conjugates comprising anthracycline derivatives
JP7291395B2 (ja) IgG結合ペプチド、及び該ペプチドによる抗体の特異的修飾
Hong et al. Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy
JP2021502810A5 (enExample)
Friedman et al. Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
CN107614514B (zh) 利用IgG结合肽的抗体特异性修饰
JP6105479B2 (ja) 血清アルブミンに結合する設計リピートタンパク質
JP2019522490A5 (enExample)
CN105142675A (zh) 通过序列特异性转肽酶制备免疫配体/效应分子结合物的方法
RU2017144606A (ru) Иммуноцитокины на основе il-15 и il-15rа домена sushi
EA200800696A1 (ru) Полипептиды и антитела
JP2021524275A5 (enExample)
JP2015509097A5 (enExample)
JP2007526880A5 (enExample)
RU2014120536A (ru) Белки специфического связывания и их применения
JP2012500006A5 (enExample)
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
CN111971060A (zh) 募集抗体并靶向肿瘤细胞的双功能分子
JP2019511201A5 (enExample)
JP2020500885A5 (enExample)
CN107849147A (zh) 基于二泛素突变蛋白的Her2 结合蛋白
JP2018530331A5 (enExample)
JP2015520172A5 (enExample)